Clinical Trial Update: Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study [Phase 3]

View source ↗

Summary

ZEUS is a Phase 3 trial evaluating a zotarolimus-eluting Endeavor Sprint stent in uncertain DES candidates for coronary artery disease, and the current trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Endeavor Sprint Zotarolimus-Eluting Stent (zotarolimus-eluting Endeavor Sprint stent)

Snippet

Sponsor: Marco Valgimigli | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN